Lincoln Pharmaceuticals informs about disclosure

07 Jun 2022 Evaluate

Lincoln Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashish Rajanbhai Patel & PACs.

The above information is a part of company’s filings submitted to BSE

Lincoln Pharma Share Price

610.85 17.00 (2.86%)
02-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1694.65
Dr. Reddys Lab 1217.60
Cipla 1193.40
Zydus Lifesciences 864.25
Lupin 2276.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×